Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Keryx / AOI Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00401011
First received: November 15, 2006
Last updated: February 7, 2012
Last verified: February 2012